Home Cart 0 Sign in  
X

[ CAS No. 4728-12-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 4728-12-5
Chemical Structure| 4728-12-5
Chemical Structure| 4728-12-5
Structure of 4728-12-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 4728-12-5 ]

Related Doc. of [ 4728-12-5 ]

Alternatived Products of [ 4728-12-5 ]

Product Details of [ 4728-12-5 ]

CAS No. :4728-12-5 MDL No. :MFCD04119722
Formula : C7H14O3 Boiling Point : -
Linear Structure Formula :- InChI Key :BTAUZIVCHJIXAX-UHFFFAOYSA-N
M.W : 146.18 Pubchem ID :3584869
Synonyms :

Calculated chemistry of [ 4728-12-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 37.02
TPSA : 38.69 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.2 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.83
Log Po/w (XLOGP3) : -0.01
Log Po/w (WLOGP) : 0.38
Log Po/w (MLOGP) : 0.09
Log Po/w (SILICOS-IT) : 1.11
Consensus Log Po/w : 0.68

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.67
Solubility : 31.0 mg/ml ; 0.212 mol/l
Class : Very soluble
Log S (Ali) : -0.35
Solubility : 64.8 mg/ml ; 0.443 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.81
Solubility : 22.6 mg/ml ; 0.155 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.8

Safety of [ 4728-12-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4728-12-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 4728-12-5 ]
  • Downstream synthetic route of [ 4728-12-5 ]

[ 4728-12-5 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 82962-54-7 ]
  • [ 4728-12-5 ]
YieldReaction ConditionsOperation in experiment
96% With lithium aluminium tetrahydride In diethyl ether at 20℃; for 3 h; Inert atmosphere To a suspension of LiAihh (0.50 g . 13.2 mmol) in Ε2υ (30 ml) was added a solution of 18.4 (2.0? g . 1 1 mmoL) in E0 (30 ml.) dropwise under argon. The reaction mixture was stirred at r.t for 3 hr. The reaction was quenched with water (0.9 roU, filtered, and the filtrate was washed with E0 . The combined organic layers were dried and concentrated under reduced pressure to give 18.5 ( 1.56 g, 96percent) as a colorless oil. 1 H MR (400 MHz, DMSO~c δ 4.52 (i J=5.2H , 1 H), 3.81 (q, 2H), 3.60 (q, 2H), 3.38 (q, 2H). 1.70 (m, 1H), 1.29 (, 6H).
76%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 25℃; for 2.33333 h;
Stage #2: With water; sodium sulfate In tetrahydrofuran; ethyl acetate at 25℃; for 1 h;
A solution of 2,2-dimethyl-[1,3]dioxane-5-carboxylic acid ethyl ester (7.03 g, 37.35 mmol) in tetrahydrofuran (20 ml) was added dropwise to a cooled to 0° C. suspension of lithium aluminum hydride (1.8 g, 48.55 mmol) in tetrahydrofuran (20 ml). The reaction was stirred at 0° C. for 20 min and at 25° C. for 2 h. After such time, ethyl acetate (1 ml) and a few crystals of sodium sulphate decahydrate were added with caution. After stirring at 25° C. for 1 h saturated sodium chloride solution was added and the product extracted with ethyl acetate (3.x.100 ml). The organics were washed with water, dried over magnesium sulfate, filtered and concentrated in vacuo to afford (2,2-dimethyl-[1,3]dioxan-5-yl)-methanol (4.09 g, 76percent) as a clear oil: 1H NMR (300 MHz, CDCl3) δ ppm 1.39 (s, 3 H, CH3), 1.44 (s, 3 H, CH3), 1.79-1.90 (m, 1 H, CH), 2.15-2.26 (brs, 1 H, OH), 3.69-3.81 (m, 2 H, 2.x.OCH of 2.x.OCH2), 3.74 (d, J=6.8 Hz, 2 H, OCH2), 3.96-4.05 (m, 2 H, 2.x.OCH of 2.x.OCH2).
75.2% With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 2.33333 h; Inert atmosphere Under nitrogen, to a solution of LiAlH4 (1.39 g, 36.58 mmol) in THF (40 mL) which was cooled to 0° C., compound Ij″-1 (5.29 g, 28.0 mmol) (according to the synthesis procedure in the patent WO 2008/0021032) was added dropwise. The mixture was stirred for 20 minutes at 0° C. and 2 hours at room temperature. When the reaction finished, the mixture was diluted with Et2O (30 mL). With an ice bath, H2O (0.14 mL) was added dropwise to the mixture, followed with NaOH solution (15percent, 0.14 mL) and H2O (0.42 mL) in sequence. After the mixture was stirred for 20 minutes at room temperature, appropriate amount of MgSO4 was added to it and then another 20 minutes for stirring proceeded. After filtration, the filtrate was concentrated under vacuum to afford compound Ii″-1 (3.1 g, 75.2percent). [0138] 1HNMR (500MHz, CDCl3) δ: 3.93-3.96 (m, 2H), 3.65-3.72 (m, 4H), 1.73-1.79 (m, 1H), 1.35(d, J=25.0 HZ, 6H).
75.2% With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 2.33333 h; Inert atmosphere Example 7: Preparation of compound Ii"-1: [0094] Under nitrogen, to a solution of LiAlH4 (1.39 g, 36.58 mmol) in THF (40 mL) which was cooled to 0°C, compoundIj"-1 (5.29 g, 28.0 mmol) (according to the synthesis procedure in the patent WO 2008/0021032) was added dropwise.The mixture was stirred for 20 minutes at 0°C and 2 hours at room temperature. When the reaction finished, the mixturewas diluted with Et2O (30 mL). With an ice bath, H2O (0.14 mL) was added dropwise to the mixture, followed with NaOHsolution (15percent, 0.14 mL) and H2O (0.42 mL) in sequence. After the mixture was stirred for 20 minutes at room temperature,appropriate amount of MgSO4 was added to it and then another 20 minutes for stirring proceeded. After filtration, thefiltrate was concentrated under vacuum to afford compound Ii"-1 (3.1 g, 75.2percent).1HNMR (500MHz, CDCl3) δ: 3.93-3.96 (m, 2H), 3.65-3.72 (m, 4H), 1.73-1.79 (m, 1H), 1.35 (d, J=25.0HZ, 6H).
58% With lithium aluminium tetrahydride In tetrahydrofuran for 2 h; Inert atmosphere; Reflux LiAlH4 (60 g, 1.58 mol) was suspended in dry THF (500 mL) under inert atmosphere. The solution of 3 (188 g,1 mol) in THF (600 mL) was added dropwise and the mixture was refluxed for 2 hours. The mixture was quenched by 6M NaOH solution upon cooling and filtered; the precipitate was washed by ethyl acetate (300 mL). The solvents were evaporated and the residual oil was distilled yielding S3 (85 g, 58percent) as colorless liquid 1. 1H NMR (700 MHz, CDCl3, 300K): δ = 4.02 (dd, J = 4.3 Hz, 12.2 Hz, 2 H), 3.78 (dd, J = 5.8 Hz,12.2 Hz, 2 H), 3.76 (dd, J = 5.1 Hz, 6.6 Hz, 2 H), 1.83-1.87 (m, 1H), 1.66 (t, J = 5.1 Hz, 1 H),1.45 (s, 3 H), 1.41 (s, 3 H).

Reference: [1] Tetrahedron, 1991, vol. 47, # 6, p. 1001 - 1012
[2] Patent: WO2013/170030, 2013, A1, . Location in patent: Page/Page column 56
[3] Journal of Organic Chemistry, 1986, vol. 51, # 14, p. 2637 - 2641
[4] Journal of the American Chemical Society, 1987, vol. 109, # 26, p. 8071 - 8081
[5] Patent: US2008/21032, 2008, A1, . Location in patent: Page/Page column 81
[6] Patent: US2013/324464, 2013, A1, . Location in patent: Paragraph 0137; 0138
[7] Patent: EP2676965, 2013, A1, . Location in patent: Paragraph 0093; 0094
[8] Synlett, 2017, vol. 28, # 5, p. 583 - 588
[9] Chemical and Pharmaceutical Bulletin, 1993, vol. 41, # 2, p. 339 - 345
[10] Patent: US4336408, 1982, A,
[11] Collection of Czechoslovak Chemical Communications, 2007, vol. 72, # 7, p. 965 - 983
[12] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 24, p. 7358 - 7360
  • 2
  • [ 4704-94-3 ]
  • [ 77-76-9 ]
  • [ 4728-12-5 ]
YieldReaction ConditionsOperation in experiment
99% at 20℃; (2, 2-Dimethyl-fl, 3] dioxan- 5 -yl) -methanol[0682] A solution of 2,2-dimethoxypropane (5.88 g, 56.5 mmol), 2-methyl- propane-l,3-diol (5.0 g, 47 mmol), and PTSA monohydrate (0.48 g, 2.3 mmol) in THF (100 mL) was stirred O/N at rt. The mixture was concentrated in vacuo to give the title compound as a colorless liquid: yield 6.87 g (99percent).[0683] 1H NMR (400 MHz, CDCl3) δ (ppm): 4.03 (dd, J= 11.7, 3.5 Hz, 2H), 3.84- 3.73 (m, 4H), 2.49-2.39 (m, IH), 1.90-1.80 (m, IH), 1.45 (s, 3H), 1.40 (s, 3H).
95%
Stage #1: With toluene-4-sulfonic acid In tetrahydrofuran at 20℃; for 3 h;
Stage #2: With triethylamine In tetrahydrofuran
To tetrahydrofuran suspension (150 ml) of 13 (4.90 g, 46.17 mmol), acetone dimethyl acetal (6.56 ml, 53.54 mmol) and toluene sulfonic acid hydrate (0.26 g, 1.39 mmol) were added while shaking at room temperature, and stirred for 3 hours at room temperature.
The reaction mixture was added triethylamine (3 ml), and evaporated to dryness under reduced pressure.
The residue was purified by silica gel column chromatography (solvent: chloroform/methanol = 10/1), to obtain 14 (6.38 g, 95percent) of oily colorless substance. APCI-MS m/z 147[M+H]+
91% With toluene-4-sulfonic acid In tetrahydrofuran at 20℃; for 2 h; To a 100 mL round bottomed flask equipped with a magnetic stir bar containing THF (75 mL) was placed a (4 g, 38 mmol, 1 equiv). To this solution was added b (4.5 g, 43 mmol, 1.15 equiv), PTSA (0.2 g, 1.1 mmol, 0.03 equiv) and the reaction was allowed to stir at room temperature for 2 h. After the reaction was complete, solvent was removed in vacuo. The residue was purified over silica gel. Product eluted out in 60percent EtOAc:Hexanes mixture in a gradient elution on a Combiflash purification system. Isolated 86 (5 g, 91percent) as a colorless oil. MS: [M+H]+: 147.
73% at 20℃; for 51 h; Example 25 1 -(3 -(3 -hvdroxy-2-(hvdroxymethyl)propoxy)-4-methyl- 1 -phenyl- 1 H-pyrazol-5-yl)-3 -(2- phenyl-8-(trifluoromethyl)imidazo[ 1 ,2-a]pyridin-3-yl)urea [00651] Step A: Preparation of (2,2-dimethyl-l,3-dioxan-5-yl)methanol: To a suspension of 2-(hydroxymethyl)propane-l,3-diol (5.0 g, 47.1 mmol) in THF (100 mL) was added pTsOH (269 mg, 1.41 mmol) followed by 2,2-dimethoxypropane (6.72 mL, 54.7 mmol). The solution was stirred for 3 hours at ambient temperature then treated with pTsOH (200 mg) and stirred at ambient temperature for 48 hours. Triethylamine (3 mL) was added and the mixture concentrated under vacuum. The residue was purified silica column chromatography eluting with 5percent MeOH/DCM to afford (2,2-dimethyl-l,3-dioxan-5- yl)methanol (5.04 g, 73percent yield) as a colorless liquid. 1H NMR (CDC13) δ 4.02 (dd, J = 12.0, 4.1 Hz, 2H), 3.74-3.80 (m, 4H), 1.90 (t, J= 5.1 Hz, 1H), 1.78-1.88 (m, 1H), 1.45 (s, 3H), 1.40 (s, 3H) ppm.
44% With toluene-4-sulfonic acid In tetrahydrofuran at 20℃; for 60 h; 2-(Hydroxymethyl)-1 ,3-propanediol (1.0 g, 9.4 mmol), 2,2-bis(methyloxy)propane (2.3 ml_, 18.8 mmol) and p-toluenesulfonic acid monohydrate (0.09 g, 0.5 mmol) were <n="69"/>dissolved in THF and stirred for -60 h. To the solution was added triethyl amine (1.0 ml.) and the solvent was evaporated. Purification was accomplished by column chromatography (CH2CI2: MeOH) to afford the title compound (0.6 g, 44percent) as a oil. 1H NMR (400 MHz, DMSOd6): δ ppm 4.52 (t, 1 H), 3.80 (dd, 2 H), 3.59 (dd, 2 H), 3.36 (dd, 2 H), 1.63 - 1.72 (m, 1 H), 1.28 (d, 6 H).

Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 26, p. 5694 - 5709
[2] Patent: WO2008/157726, 2008, A1, . Location in patent: Page/Page column 210
[3] Patent: EP2103611, 2009, A1, . Location in patent: Page/Page column 51-52
[4] Patent: WO2008/124703, 2008, A2, . Location in patent: Page/Page column 84
[5] Journal of Medicinal Chemistry, 1990, vol. 33, # 1, p. 187 - 196
[6] Patent: WO2014/78408, 2014, A1, . Location in patent: Paragraph 00651
[7] Patent: WO2008/154271, 2008, A1, . Location in patent: Page/Page column 67-68
[8] Journal of Medicinal Chemistry, 2005, vol. 48, # 19, p. 5980 - 5988
[9] European Journal of Organic Chemistry, 2006, # 3, p. 719 - 728
[10] Journal of Organic Chemistry, 2007, vol. 72, # 10, p. 3952 - 3954
[11] Patent: WO2006/79916, 2006, A1, . Location in patent: Page/Page column 91
[12] Patent: WO2008/63912, 2008, A1, . Location in patent: Page/Page column 54
[13] Patent: WO2008/86122, 2008, A2, . Location in patent: Page/Page column 75
[14] European Journal of Medicinal Chemistry, 2009, vol. 44, # 1, p. 239 - 250
[15] Patent: WO2009/129385, 2009, A1, . Location in patent: Page/Page column 84
[16] Patent: US2009/291962, 2009, A1, . Location in patent: Page/Page column 17-18
[17] Patent: EP2079711, 2010, B1, . Location in patent: Page/Page column 29
[18] ACS Medicinal Chemistry Letters, 2010, vol. 1, # 7, p. 321 - 325
[19] Organic Process Research and Development, 2012, vol. 16, # 9, p. 1527 - 1537
[20] Patent: WO2008/157330, 2008, A1, . Location in patent: Page/Page column 67
  • 3
  • [ 4704-94-3 ]
  • [ 67-64-1 ]
  • [ 4728-12-5 ]
YieldReaction ConditionsOperation in experiment
85.8%
Stage #1: With perchloric acid In water at 20℃; for 21 h;
Stage #2: With ammonium hydroxide In water
A mixture of 2-(hydroxymethyl)-1,3-propanediol (4.09 g, 38.5 mmol), acetone (130 ml, 1768 mmol) and 70percent perchloric acid (1.37 g, 9.55 mmol) was stirred at room temperature for 21 hours. After the pH of the reaction mixture was adjusted with concentrated aqueous ammonia to 9, the reaction mixture was concentrated. The residue was purified by silica gel column chromatography (silica gel: 100 g, elution solvent: heptane, heptane/ethyl acetate=1/3) to obtain the title compound (4.83 g, yield: 85.8percent) as a colorless oil. 1H NMR(400 MHz, DMSO-d6) δppm; 1.29(3H, s), 1.30(3H, s), 1.64-1.74(1H, m), 3.35-3.41(2H, m), 3.61(2H, dd, J=7, 12 Hz), 3.82(2H, dd, J=4, 12 Hz), 4.54(1H, t, J=5 Hz).
85.8% With perchloric acid In water at 20℃; for 21 h; A mixture of 2-(hydroxymethyl)-1,3-propanediol (4.09 g, 38.5 mmol), acetone (130 ml, 1.768 mmol) and 70percent perchloric acid (1.37 g, 9.55 mmol) was stirred for 21 hours at room temperature. The reaction mixture was concentrated after adjusting to pH 9 with concentrated ammonia. The residue was purified by silica gel column chromatography (silica gel: 100 g, elution solvent: heptane, heptane/ethyl acetate = 1/3) to obtain the target compound (4.83 g, yield: 85.8percent) as a colorless oily substance. 1H-NMR (400 MHz, DMSO-d6) δppm: 1.29 (3H,s), 1.30 (3H,s), 1.64-1.74 (1H,m), 3.35-3.41 (2H,m), 3.61 (2H,dd,J=7,12 Hz), 3.82 (2H,dd,J=4,12 Hz), 4.54 (1H,t,J=5 Hz)
85.8% With perchloric acid In water at 20℃; for 21 h; (Production Example 1) (2,2-dimethyl-1,3-dioxan-5-yl)methanol [Show Image] A mixture of 2-(hydroxymethyl)-1,3-propanediol (4.09 g, 38.5 mmol), acetone (130 ml, 1768 mmol) and 70percent perchloric acid (1.37 g, 9.55 mmol) was stirred for 21 hours at room temperature. The pH of the reaction mixture was adjusted to 9 with concentrated aqueous ammonia and the reaction mixture was concentrated. The residue was purified by silica gel column chromatography (silica gel: 100 g, elution solvent: heptane, heptane/ethyl acetate= 1/3) to produce the title compound (4.83 g, yield: 85.8percent) as a colorless oil. 1H NMR (400 MHz, DMSO-d6) δ ppm; 1.29 (3H, s), 1.30 (3H, s), 1.64-1.74 (1H, m), 3.35-3.41 (2H, m), 3.61 (2H, dd, J=7, 12Hz), 3.82 (2H, dd, J=4, 12Hz), 4.54 (1H, t, J=5Hz).
85.8% at 20℃; for 21 h; (1 ) (2.2-Dimethyl-1.3-dioxan-5-vπmethanolA mixture of 2-(hydroxymethyl)-1 ,3-propanedior(4.09 g, 38.5 mmol), acetone (130 ml, 1768 mmol), and 70percent perchloric acid (1.37 g, 9.55 mmol) was stirred at room temperature for 21 hours. A pH of the reaction mixture was adjusted to 9 using concentrated ammonia water, and then subjected to concentration. The residue was purified by silica gel column chromatography (silica gel: 100 g, eluent: heptane, heptane / ethyl acetate = 1 / 3), whereby the title compound (4.83 g, percentage yield 85.8percent) was obtained as a colorless oil. 1H-NMR (400 MHz, DMSO-d6) δ ppm: 1.29 (3H, s), 1.30 (3H, s), 1.64-1.74 (1 H, m), 3.35-3.41 (2H1 m), 3.61 (2H, dd, J = 7, 12 Hz), 3.82 (2H, dd, J = 4, 12 Hz), 4.54 (1 H, t, J = 5 Hz).

Reference: [1] Patent: US2007/10542, 2007, A1, . Location in patent: Page/Page column 38
[2] Patent: EP2065379, 2009, A1, . Location in patent: Page/Page column 18-19
[3] Patent: EP2077265, 2009, A1, . Location in patent: Page/Page column 15
[4] Patent: WO2008/47849, 2008, A1, . Location in patent: Page/Page column 38
[5] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 20, p. 2909 - 2914
[6] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 20, p. 6104 - 6107
[7] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 15, p. 4008 - 4030
[8] Journal of Medicinal Chemistry, 2017, vol. 60, # 17, p. 7539 - 7554
  • 4
  • [ 155818-14-7 ]
  • [ 4728-12-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1996, vol. 39, # 14, p. 2795 - 2811
[2] Tetrahedron Asymmetry, 2004, vol. 15, # 18, p. 2811 - 2815
  • 5
  • [ 51335-75-2 ]
  • [ 4728-12-5 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1993, vol. 41, # 2, p. 339 - 345
[2] Journal of the American Chemical Society, 1987, vol. 109, # 26, p. 8071 - 8081
[3] Journal of Organic Chemistry, 1986, vol. 51, # 14, p. 2637 - 2641
[4] Tetrahedron, 1991, vol. 47, # 6, p. 1001 - 1012
[5] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 24, p. 7358 - 7360
[6] Patent: WO2013/170030, 2013, A1,
[7] Synlett, 2017, vol. 28, # 5, p. 583 - 588
[8] Patent: US2008/21032, 2008, A1,
  • 6
  • [ 111934-93-1 ]
  • [ 4728-12-5 ]
Reference: [1] Tetrahedron Asymmetry, 2004, vol. 15, # 18, p. 2811 - 2815
[2] Journal of Medicinal Chemistry, 1996, vol. 39, # 14, p. 2795 - 2811
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 4728-12-5 ]

Alcohols

Chemical Structure| 22323-82-6

[ 22323-82-6 ]

(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol

Similarity: 0.77

Chemical Structure| 14347-78-5

[ 14347-78-5 ]

(R)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methanol

Similarity: 0.77

Chemical Structure| 16777-87-0

[ 16777-87-0 ]

3,3-Diethoxy-1-propanol

Similarity: 0.71

Chemical Structure| 5754-34-7

[ 5754-34-7 ]

2-(2,2-Dimethyl-1,3-dioxolan-4-yl)ethanol

Similarity: 0.69

Chemical Structure| 1256546-72-1

[ 1256546-72-1 ]

1,4-Dioxaspiro[4.5]decane-8,8-diyldimethanol

Similarity: 0.67

Related Parent Nucleus of
[ 4728-12-5 ]

Aliphatic Heterocycles

Chemical Structure| 22323-82-6

[ 22323-82-6 ]

(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol

Similarity: 0.77

Chemical Structure| 14347-78-5

[ 14347-78-5 ]

(R)-(2,2-Dimethyl-1,3-dioxolan-4-yl)methanol

Similarity: 0.77

Chemical Structure| 40137-24-4

[ 40137-24-4 ]

2,2-Dimethyl-1,3-dioxan-5-amine

Similarity: 0.70

Chemical Structure| 82962-54-7

[ 82962-54-7 ]

Ethyl 2,2-dimethyl-1,3-dioxane-5-carboxylate

Similarity: 0.70

Chemical Structure| 57280-22-5

[ 57280-22-5 ]

4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

Similarity: 0.69

Other Aliphatic Heterocycles

Chemical Structure| 74181-34-3

[ 74181-34-3 ]

2,2-Dimethyl-1,3-dioxan-5-one

Similarity: 0.75

Chemical Structure| 40137-24-4

[ 40137-24-4 ]

2,2-Dimethyl-1,3-dioxan-5-amine

Similarity: 0.70

Chemical Structure| 82962-54-7

[ 82962-54-7 ]

Ethyl 2,2-dimethyl-1,3-dioxane-5-carboxylate

Similarity: 0.70

Chemical Structure| 57280-22-5

[ 57280-22-5 ]

4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

Similarity: 0.69

Chemical Structure| 78-19-3

[ 78-19-3 ]

3,9-Divinyl-2,4,8,10-tetraoxaspiro[5.5]undecane

Similarity: 0.69